Paradigm Biopharmaceuticals Limited (ASX:PAR)
0.175
-0.020 (-10.26%)
Apr 29, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 88.10 million as of April 28, 2026. Its market cap has decreased by -25.83% in one year.
Market Cap
88.10M
Enterprise Value
82.74M
Revenue
8.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 88.10M, an increase of 171.86%. That is a compound annual growth rate of 9.80%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 84.66M |
| Botanix Pharmaceuticals | 89.77M |
| Cynata Therapeutics | 80.73M |
| Arovella Therapeutics | 93.08M |
| Radiopharm Theranostics | 74.43M |
| LTR Pharma | 70.89M |
| Immutep | 104.63M |
| Island Pharmaceuticals | 110.84M |